Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

264
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
264
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

637
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
637
Depressants01:28

Depressants

236
Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
236
Diagnostic and Statistical Manual of Mental Disorders (DSM)01:27

Diagnostic and Statistical Manual of Mental Disorders (DSM)

401
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
401
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

885
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
885
Stress Prevention and Stress Management Techniques IV01:26

Stress Prevention and Stress Management Techniques IV

106
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
106

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial.

Lancet (London, England)·2026
Same author

GLP-1 Receptor Agonist Medications: Interactions With Addiction Neurocircuitry.

Biological psychiatry·2026
Same author

Phosphatidylethanol as an objective measure of heavy drinking days in a clinical trial for alcohol use disorder.

Alcohol and alcoholism (Oxford, Oxfordshire)·2026
Same author

Semaglutide and Early-Stage Metabolic Abnormalities in Individuals With Schizophrenia Spectrum Disorders: A Randomized Clinical Trial.

JAMA psychiatry·2025
Same author

Antipsychotic polypharmacy in patients with schizophrenia between 1999 and 2024 in Denmark: Prevalence, time trends, and combinations.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2025
Same author

Brain structural correlates of prior alcohol use disorder and their relation to cognitive impairment in individuals with mood disorders.

Journal of affective disorders·2025
Same journal

[Mosaicism as a cause of Cowden syndrome].

Ugeskrift for laeger·2026
Same journal

[Thyrotoxic crisis with cardiogenic shock].

Ugeskrift for laeger·2026
Same journal

[Mindfulness-based cognitive therapy in the treatment of depression].

Ugeskrift for laeger·2026
Same journal

[Fitness].

Ugeskrift for laeger·2026
Same journal

[Risk of developing cataract related to fluoroscopy].

Ugeskrift for laeger·2026
Same journal

[Obturator hernia with small bowel ileus presenting as hip pain in an elderly woman].

Ugeskrift for laeger·2026
See all related articles

Related Experiment Video

Updated: Nov 9, 2025

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
05:12

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Published on: June 23, 2023

1.2K

[Alcohol use disorders and comorbidity].

Anders Fink-Jensen1

  • 1anders.fink-jensen@regionh.dk.

Ugeskrift for Laeger
|April 9, 2021
PubMed
Summary
This summary is machine-generated.

Alcohol use disorders (AUD) frequently co-occur with other psychiatric conditions, posing a global health challenge. Early screening using tools like the Alcohol Use Disorder Identification Test is crucial for better patient outcomes.

More Related Videos

Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice
07:31

Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice

Published on: January 7, 2019

8.3K
Modeling Alcohol Consumption in Rodents Using Two-Bottle Choice Home Cage Drinking and Microstructural Analysis
08:45

Modeling Alcohol Consumption in Rodents Using Two-Bottle Choice Home Cage Drinking and Microstructural Analysis

Published on: November 8, 2024

923

Related Experiment Videos

Last Updated: Nov 9, 2025

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
05:12

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Published on: June 23, 2023

1.2K
Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice
07:31

Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice

Published on: January 7, 2019

8.3K
Modeling Alcohol Consumption in Rodents Using Two-Bottle Choice Home Cage Drinking and Microstructural Analysis
08:45

Modeling Alcohol Consumption in Rodents Using Two-Bottle Choice Home Cage Drinking and Microstructural Analysis

Published on: November 8, 2024

923

Area of Science:

  • Psychiatry
  • Addiction Medicine
  • Public Health

Background:

  • Alcohol use disorders (AUD) are highly prevalent psychiatric conditions.
  • AUD frequently co-occur with other mental health disorders, including affective, anxiety, personality, and psychotic disorders.
  • This psychiatric comorbidity represents a significant global health burden, often remaining undiagnosed and untreated.

Purpose of the Study:

  • To highlight the significant issue of psychiatric comorbidity in patients with alcohol use disorders.
  • To emphasize the need for increased awareness and early detection of AUD in psychiatric populations.
  • To introduce and describe the Alcohol Use Disorder Identification Test (AUDIT) as a valuable screening tool.

Main Methods:

  • This review synthesizes existing literature on the comorbidity of alcohol use disorders and other psychiatric conditions.
  • It discusses the implications of this comorbidity for patient care and public health.
  • The review details the utility and application of the Alcohol Use Disorder Identification Test (AUDIT).

Main Results:

  • Psychiatric comorbidity is a common and often overlooked aspect of alcohol use disorders.
  • Effective screening for AUD in psychiatric settings can improve recognition and treatment rates.
  • The Alcohol Use Disorder Identification Test (AUDIT) is presented as a practical and effective screening instrument.

Conclusions:

  • Increased awareness of alcohol use disorders among psychiatric patients is essential.
  • Routine screening for AUD in psychiatric populations, utilizing tools like AUDIT, is recommended.
  • Addressing psychiatric comorbidity in AUD is critical for improving patient outcomes and reducing the global health burden.